| Hoffmann-La Roche Inc. is an affiliate of the multinational group of companies headed by Roche Holding Ltd. of Basel, Switzerland. Its is one of the world's leading research-oriented companies, Roche has discovered, developed and introduced numerous innovative prescription pharmaceuticals designed to fulfill unmet medical needs.
More Information
The Food and Drug Administration's (FDA) unanimously recommended the approval of Xenical(R) (orlistat) to help people lose weight and decrease other health risks on May l4, 1997. Xenical was discovered and developed by Hoffmann-La Roche.
Xenical represents the first of a new class of non-systemic, anti-obesity drugs called lipase inhibitors, or fat blockers, which act in the gastrointestinal tract to prevent the absorption of fat by about 30 percent. Drugs in this class do not achieve their effect through brain chemistry.
|
